Halofuginone inhibits colorectal cancer growth through suppression of Akt/mTORC1 signaling and glucose metabolism-Reference-Cited by-同舟云学术

Halofuginone inhibits colorectal cancer growth through suppression of Akt/mTORC1 signaling and glucose metabolism

Published:2015-06-08 Issue:27 Volume:6 Page:24148-24162
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Chen Guo-Qing¹²,Tang Cheng-Fang³⁴,Shi Xiao-Ke¹,Lin Cheng-Yuan¹,Fatima Sarwat¹,Pan Xiao-Hua⁵,Yang Da-Jian²,Zhang Ge¹,Lu Ai-Ping¹,Lin Shu-Hai¹³,Bian Zhao-Xiang¹

Affiliation:

1. Laboratory of Brain and Gut Research, Center for Clinical Research on Chinese Medicine, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR, China

2. Chongqing Academy of Chinese Materia Medica, Chongqing, China

3. Department of Chemistry and State Key Laboratory of Environmental and Biological Analysis, Hong Kong Baptist University, Hong Kong SAR, China

4. Instrument and Testing Center, Sun Yat-Sen University, Guangzhou, China

5. Shen Zhen People's Hospital, Shenzhen, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural Products and Derivatives Targeting Metabolic Reprogramming in Colorectal Cancer: A Comprehensive Review;Metabolites;2024-09-09

2. New uses of halofuginone to treat cancer;Journal of Pharmaceutical Analysis;2024-08

3. DWN12088, A Prolyl-tRNA Synthetase Inhibitor, Alleviates Hepatic Injury in Nonalcoholic Steatohepatitis;Diabetes & Metabolism Journal;2024-01-31

4. Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer;Acta Pharmaceutica Sinica B;2023-12

5. Phytochemicals targeting glycolysis in colorectal cancer therapy: effects and mechanisms of action;Frontiers in Pharmacology;2023-08-24